Genedrive UK Study Supports Clinical Adoption of Genedrive Newborn Hearing Loss Test Within NHS Premium The assay and point-of-care device were implemented in a trial in cooperation with clinical partners based at Manchester University NHS Foundation Trust. Genedrive Rapid Molecular COVID-19 Test Receives CE Mark The point-of-care test uses RT-LAMP technology and returns positive results in eight minutes and negative results in 17 minutes. Genedrive Receives CE Mark for Next-Generation Gene Amplification Platform The system was developed to support the commercial launch of Genedrive's MT-RNR1 test for antibiotic-induced hearing loss in newborns. Genedrive Expects CE-IVD Mark for POC SARS-CoV-2 Test by Fall; Advances Hearing Loss, HCV Assays Premium The Manchester, UK-based company had previously planned to have a CE-IVD marked test out by June 30. Genedrive Inks Distribution Agreement With Beckman Coulter for SARS-CoV-2 PCR Tests Under the agreement, Beckman Coulter will sell and distribute Genedrive's high-throughput SARS-CoV-2 test in the US and Europe. Aug 6, 2020 Genedrive, Beckman Coulter Life Sciences Partner on Automated PCR Testing for SARS-CoV-2 May 22, 2020 Genedrive Receives CE Mark for SARS-CoV-2 PCR Kit May 5, 2020 Genedrive Hepatitis C Test Garners WHO Prequalification, Firm Plans £8M Raise Jan 27, 2020 UK Newborn Trial to Assess PCR Test for Antibiotic-Induced Hearing Loss Nov 21, 2019 Genedrive Receives CE Mark for Hearing Loss Assay Aug 23, 2019 Genedrive Prepping for UK Commercial Launch of PGx Test for Neonatal Hearing Loss Premium Aug 8, 2018 Genedrive, FIND Partner on HCV Assay Evaluation Study Jun 20, 2018 Genedrive Receives UK NIHR Grant for Antibiotic-Related Hearing Loss Assay Jun 19, 2018 UK Researchers Develop Rapid POC Test for Antibiotic-Related Hearing Loss Premium Jun 15, 2018 In Brief This Week: Genedrive, Exosome Dx, Luminex, More Breaking News Canadian Healthcare Providers, Policymakers Value Different Aspects of Clinical Genomic Sequencing New Products Posted to GenomeWeb: Oxford Nanopore, Bio-Rad, NanoString, More People in the News at OraSure, Element Biosciences, Micronoma, More Guardant Health Files Motions to Dismiss, Change Venue in Illumina Patent Lawsuit In Brief This Week: SQI Diagnostics, T2 Biosystems, Enhanc3D, QuidelOrtho, More Illumina, Precision Health Research Singapore Partner for 100K Genomes Population Study The Scan Blend of Omicron With Delta The Associated Press reports that currently circulating Omicron variants have some features previously seen in the Delta variant. Limited Contrast The New York Times reports that there is a shortage of a contrast agent used for some medical scans. Pig Improvement Farmers in China are using genetics to improve their hog herds, according to Reuters. Science Papers Present Way to Molecularly Classify Prostate Cancer, Saliva-Based SARS-CoV-2 Test, More In Science this week: approach to molecularly classify prostate tumors, saliva-based test for SARS-CoV-2, and more.